Designed high-affinity antibodies (50 pM) against a novel target for academic research in just 8 weeks with high specificity.
An academic research group needed high-affinity antibodies against a novel membrane protein target for their cancer research. No existing antibodies were commercially available, and traditional hybridoma approaches were time-consuming and uncertain.
They needed antibodies with picomolar affinity for use in western blot, immunohistochemistry (IHC), and flow cytometry applications.